Impact of Dutasteride on PSA Kinetics and Time to Progression in Men with PSA-only Recurrent Prostate Cancer - Charles E Myers, Michelle S McCarthy - TFCR&E - posted pre-pub May 5, 2021.
The legendary Snuffy Myers may be retired from the clinic, but he keeps on working to broaden the treatment options for PCa. A true pioneer still blazing trails on our behalf via the foundation he created to contimue his research. The link to his foundation, The Foundation For Cancer Research & Education, is here:
This particular research shows convincing benefit from daily use of dutasteride (Avodart) in non-metastatic PSA-only recurrent prostate cancer. I know we have some members who will vouch for the effectiveness of Avodart in managing their own disease state.
Abstract
Background: AVODART After Radical Therapy For Prostate Cancer Study (ARTS) reported dutasteride reduced PSA doubling (PSADT) at two years by 66% and disease progression by 59%. The durability of the cancer control is unknown.
Objective: Explore the impact of dutasteride on PSADT and time to progression in men with PSA-only recurrent disease.
Design, Setting and Participants: Retrospective examination of the impact of dutasteride on PSA kinetics and time to progression with PSA-only recurrent prostate cancer.
Intervention Dutasteride daily.
Outcome, Measurement and Statistical Analysis: Change in PSA over time was determined by linear regression of natural log of PSA versus time. The slope of that curve was used as a measure of exponential PSA progression. Impact of dutasteride on slope was analyzed using Wilcoxon signed-rank two-sided test. Time to progression was analyzed using Kaplan-Meier, univariant and multivariant Cox regression.
Results and Limitation: Compared to men with BPH, patients showed little change in PSA during the first 3 months. Thereafter, the PSA resumed an exponential increase. PSADT was 10.3 months pre dutasteride and 24.8 months post dutasteride. Multivariant analysis showed a strong correlation between post dutasteride PSA kinetics and time to progression, with close to 50% relapse free at 10 years. Post-dutasteride, patients with PSADT >9 months had significantly better survival.
Conclusions: Dutasteride slows PSADT in PSA-only recurrent prostate cancer. This decline correlated with time to disease progression with close to 50% progression free at 10 years.
Patient Summary: Men with PSA-only recurrent prostate cancer on dutasteride experience a significant drop in the rate at which the PSA increases. If the PSA does not double between months 3-12, they are likely to remain free of metastases for many years.
The Abstract, full text and PDF download are all available here: Note that this is per-publication report and has not yet been peer reviewed.
Impact of Dutasteride on PSA Kinetics and Time to Progression in Men with PSA-only Recurrent Prostate Cancer - Charles E Myers, Michelle S McCarthy
Nal - you were the primary person I had in mind when I wrote of ". . .some members who will vouch for the effectiveness of Avodart . . .". Based on some recent lab results, I may decide to join the Avodart treat me gently club myself. I'll be looking for lab confirmation in about three weeks. Depending on results, I may be seeking your qualified opinion via messaging.
Hope all continues to be going well with you and Ms Mary and you are fully settled into your now mold-free home. That fine Smoky Mountain air should be, as my parents used to say, "Good for what ails you".
Mine was GL10 just 6 years ago and as mentioned began with castration then Dutasteride plus Metformin before the cryo, added the immuno injection 7 months later and 1 month after that began the biweekly Cypionate injections. Had a minor 6/7 recurrence in 2018 and just chill'n out, cruising along checking PSA, "T" and other blood numbers every 3 months. Playing a "wait and see game" with a respectable QOL thanks to the "T" so can't complain.
Feel guilty that things are OK for me but not so good for many others with lesser numbers. Just doesn't compute ???? 🤔
I with you. Brother. QOL is 1st priority with me as well. 3 1/2 years vacation with age-adjusted normal T levels throughout. I may be at the end of my vacation, but it was definitely the right thing at the right time for me. Everyone's mileage varies, but in both our cases it might be the quality of the ride that counts as much as the length of the trip.
Enjoy the ride. May it last a long time and you stay well for all of it - K9
I waited until getting the ADT out of my system and joined the Dutasteride club. I took it for 1 month straight and then backed off to twice a week. I will be getting testing next month, so I will stop 1 week before since Dutasteride has a long half life, as I do with supplements. Our amigo in the North takes it 3x a week I believe and is past the 2 year point. I think that bodes very well for him... The Patient Summary says it all...:
Patient Summary: Men with PSA-only recurrent prostate cancer on dutasteride experience a significant drop in the rate at which the PSA increases. If the PSA does not double between months 3-12, they are likely to remain free of metastases for many years.
I can vouch for its effectiveness. I started on Avadart 5 plus years ago (3 months post surgery- 4/2016 ) nothing else but supplements - 10,000 D3 daily / curcumin / boron / grape seed / iodine / Arimidex or Dim / etc. med diet / very few eggs mostly fish / occasional beef or pork.
In Sept 2020 -- I started taking T shots weekly to get to super physl levels --- PSA goes from high of 2.3 to currently 1.3 T was as high as 3500 (200 mg weekly) -- currently taking only 100 mg weekly T is around 700 to 800 a couple days post shot. When I first started Avadart I took it 3 days a week / now I take it daily. I went to NIH August 2019 for testing to see if I qualified for a trial --- It never happened -- the trial was cancelled March 2020 due to Covid 19 -- I was required to stop Avadart and all supplements for lead in -- so I stopped everything for nearly 6 months -- during that time my PSA went from 0.8 to 1.37 --- after which I started back on Avadart and supplements and began high dose T.
Good n=1 trial you got going on there, George. Thanks for sharing the details. As you know, there are lot of us on HU forums who are doing their own thing and it is useful to learn what others are doing and what results they are getting. Paz - K9
Glad things are working out for you.... thanks for telling some of your tale... It is interesting that some forms of Pca are less aggressive and can be treated in other ways... ADT eventually leads to castrate resistance... Have you had any kind of scan in the last 2 years??
Yes, I had a PSMA scan at NIH in January 2020 a questionable faint uptake in SV area about 1/4 inch in size otherwise negative And I had a F18 Ply scan in Houston in Dec. 2020 showed nothing. I am considering radiation of pelvic area (in the blind) you may recall, I had 4 of 10 lymph nodes positive at post surgery pathology report. If I were you I would stay on the Avadart nonstop rather than stopping for a month prior to getting PSA test.. It definitely slowed the doubling time for me (along with the other supplements and Dukoral). Life Extension reported on Finasteride (and Avadart) over 15 years ago. They lowered incidences of PCa in general population by 25% over 7 year study. You can find it on their website. There was a 20 year follow up report just recently that confirmed it. Snuffy has a video on it. I think in my case it is not the testosterone that fuels the cancer it is DHT. In old guys our T levels slowly decline while our DHT slowely increases causing an imbalance in the ratio -- possibly triggering the PCa. As you know young guys rarely get PCa and almost all old dudes will get it if they live long enough. And young guys have high T and relatively low DHT and old guys have low T and relatively high DHT.It took nearly 2 years for my PSA to go from 0.4 to 0.6.
I think when these guys go on ADT vacation they should immediately start Testosterone and Avadart for life. the shock to any remaining PCa cells would be the equivalent to BAT -- just don't stop the T and Avadart -- it may keep it in remission for years. At least a slow doubling time of a year or two -- you could likely out live it ... it seems no one gets cured -- the problem is the aggressive effort to get and maintain a zero PSA actually leads to CRPC> and runaway growth... Supposedly we all had cancer 8 to 10 years before it ever showed up in the first place ...
I am doing well... I do not stop Avodart for a month....only a week as I do with my supplements... I take Avodart 2x a week for now and may increase to 3x a week depending on labs . I am almost a year out off meds... I will consider adding androgel based on my next set of tests this month...
You are doing well and glad this is working for you. Not all PCa is alike and for those that do not need to be on continuous ADT, then do not use it but intermittently as it leads to resistance IMHO. For more aggressive forms, then SOC should not be avoided.
I think doing radiation to the one area is a great idea and will buy you more time off meds. Best of luck to you on the journey...
SAN FRANCISCO—After 25 years, the verdict is in on finasteride. The latest data from the landmark Prostate Cancer Prevention Trial (PCPT) allay earlier concerns that the 5-alpha-reductase inhibitor promotes lethal prostate cancer (PCa). Finasteride significantly reduces a man’s risk for PCa and is safe long-term. Principal study investigator Ian Thompson, Jr., MD, president of CHRISTUS Santa Rosa Hospital Medical Center in San Antonio, delivered the “transformational” findings at the 2018 American Urological Association Annual Meeting.
The PCPT, one of the largest cancer prevention trials, randomized 18,882 men from 1993 to 1997 to finasteride or placebo. The trial intervention was stopped in 2003 when investigators found finasteride reduced overall PCa risk by 25%, but also increased the risk for high-grade disease. This negative finding resulted in a “black box” warning from the FDA in 2011.
Subsequent SWOG analyses of PCPT data revealed unexpected benefits of finasteride. It improved detection of significant PCa, including high-grade tumors. Additional analysis showed that study participants enjoyed the same longevity whether they received finasteride or placebo. Still, despite these benefits, the black box warning had an impact. Few men today take the inexpensive generic drug to lower their cancer risk.
As part of their follow-up investigation, Dr Thompson and colleagues revisited the study and matched participants to the National Death Index, a centralized database of death records at the Centers for Disease Control and Prevention. With almost 300,000 person-years of follow-up and a median follow-up of 18.4 years, they found 42 deaths due to PCa in the finasteride arm and 56 in the placebo arm.
“What we ultimately found were fewer prostate cancer deaths with finasteride, demonstrating with prolonged follow-up that there was no greater risk of prostate cancer death with the drug, just fewer cancers,” Dr Thompson told Renal & Urology News.
These findings could benefit tens of thousands of men each year in the United States, he said. PCa treatment is costly and it can have serious side effects, such as impotence and urinary incontinence. “Urologists and their patients can now rest easy that these initial concerns regarding high-grade tumors are unfounded. Additionally, for a man who asks his physician, ‘How can I prevent prostate cancer,’ the physician can now tell him with confidence that there is a proven method to reduce his risk of this common disease.”
Scott Eggener, MD, Professor of Surgery (Urologic Oncology) at the University of Chicago Medicine, agreed these data reassure that long-term finasteride use does not increase rates of higher-grade PCa. Initially there was a debatable increased risk of higher-grade cancer 0.5% (1 in 200 men), which has largely been debunked by follow-up studies within PCPT and from other cohorts. “Although not integrated into guidelines at this point, clinicians should feel comfortable prescribing finasteride to a man with a large prostate, significant urinary symptoms from prostate obstruction, and an elevated PSA level as long as prostate cancer has been ruled out,” Dr Eggener said.
Frank J. McGovern, MD, a urologist at Massachusetts General Hospital in Boston, believes the latest findings clear up the controversy. “The data have been worked front, back, and sideways with multiple different conclusions,” Dr McGovern said. “It is a relief to get these data. There are men that have held back from taking it because of their concern about developing an aggressive tumor. This will allow men who need to be on it to take it without fear.”
Reduces the odds of getting PCa by 25% ! You keep and have full use of your testosterone so you wont become CRPC (unlike ADT or casodex).
I don't think there is any other drug on the market that can make that claim .. also -- I can safely say it slows doubling time as per cujoes article above ... It slowed my doubling time from 8 months to over 2 years. that is spectacular also !
Nothing else comes close to that .... ADT merely slows it for a while and then morphs it into a fast spreading type. Also Avadart is even better that finasteride .. so almost certainly better at slowing the growth and lowering the cases of PCa maybe more than 25%.
George, The info in your previous reply seems worthy of its own post. Thanks again for sharing your long-term success "managing" your PCa. With the tools at hand, we are all looking to do just that, aka "manage" what we all know to at best be a chronic disease.
I'm in need of developing a management strategy going forward and your info is very helpful. We outliers here at HU should start an advisory service called non-SOC Adaptive Management Strategies. I have a feeling the long term OS statistics would be much superior to SOC and provide significantly improved QOL in the bargain.
Keep traveling that n=1 road that has worked well for you so far - and Be Safe & Well.
Did you guys see Patricks post on Melatonin? In my opinion that is a must do also ... over all survival of PCa for those taking melatonin was 154 months ! compared to 81 months. Patrick says he takes 40 mg nightly -- and has been for 15 years--- I have started taking 30 mg nightly -- so far so good -- only seem to dream a little more.
I've been at 20mg for a number of years. With my measly 145 pound frame, I figure 20 for me is like 30 for the average guy. I started taking it to help with better sleep patterns. (Not that I have any problem there.) Original dose was 3 mg, then 5, up to 10 and then on to 20. The small doses initially caused some pretty vivid dreams on and off, but now I don't have anything that seems unusual.
With my recent PSA rise, I may decide to boost the dose to your 30 mg. I have read somewhere that continual use will cause you to stop producing it, but unless we get a quick cure for PCa, I figure I'll be taking it for the rest of my days, so no problem there.
Sleep Well and may you have very pleasant melatonin-induced dreams. 💤
You're in luck, as I just did a summary for Nal. Here is an abbreviated version:
. . .
In general, I would characterize myself as a "high-risk good responder".
RALP in August 2013 - PSA reached 17+ just before RALP. Post-surgery PSA nadir of 0.03 @ 6 and 12 weeks out.
Final biopsy had 3 out of the four possible negatives; i.e., not organ confined/positive margins (bi-laterally), ex-cap involvement, right seminal vesicle invasion, but negative lymph nodes (however they were unsurprisingly positive for my "other cancer", CLL). Gleason 7 (4+3), 30% of prostate involved, AJCC Stage: pT3a/3b pNx (prostate primary).
8 weeks of IMRT @ UNC 3 months post surgery (advanced schedule requested by me due to poor pathology.)
3 years of <0.1 PSA.
BCR in March 2016 with radical doubling rate.
2 set of bone and CT scans in Feb & June 2017 with no signs of metastatic disease.
PSA @ 25+ (sans-prostate) just before starting bicaludamide + Lupron ADT (3 mo depot)
PSA undetectable <0.1 and T = 9 after 3 months ADT.
I stopped ADT (long story as to how that happened, but it worked out in my favor) and 3 months later my PSA was still <0.1 undetectable and my T had risen to shocking 586, which was considerably higher than it had ever tested before. My T has averaged around 400 since stopping ADT. (BTW, it was 127 when tested for the first time at my RALP pre-op.)
I had been riding that "undetectable" horse up until my most recent Onco visit on 10 June. (explanation below.)
I started with 3 mo Onco visit (<0.1 accuracy PSA & T labs) for the first year or so after going on treatment vacation and later went to 2 x per year with local labs in-between. Local labs were x.xx acuracy until December of last year when the local hospital went to <0.1 or my cancer center requested it? My mid-year appt was teleconf, so I had 3 labs in a row locally. Those 3 labs were 0.06, 0.05, & 0.02, so I was seeing a declining trend and the 0.02 was anew post-surgery nadir. Hurrah! Maybe the cursed PCa demon has been exiled for good.
In reality I was very much looking forward to the December local lab to confirm the trend and the new nadir. Did not happen due to the change in PSA lab testing. I had planned to get a ultra-sensitive lab in March and failed to do so. (Complacency is a Bitch!) So, I go to my 10 June Onco appt and find I have a 0.24 PSA = an official second BCR. I have surmised (without certifiable evidence, but very good clinical research support) that the three surgeries I had in the last quarter of 2020 may well have shut down my CLL-weakened (second cancer) immune function enough to give the PCa a chance to awaken from its sleep stake; i.e., sort of a surgical prince kissing up to the evil cancer frog.
Currently I take a lot of supplements and plant powders, including pharma look-alikes Berberine (500 mg twice a day at/before meals) and Red Yeast Rice (1200 mg twice a day). I've also been taking Neem Leaf extract (900mg early morning and at bedtime) and Mealtonin (20 mg near bedtime). Since I also have the blood cancer CLL (untreated after 14 years), I look for supplements, foods, and spices that will have positive impacts on both cancers, thus many of the other supplements I take fall into that category.
I'll be getting a PSA lab in about 2 weeks at my annual visit with my PCP and Nal has suggested I consider also doing a DHT and maybe E2 to see what the hormone balance looks like. I'm not sure if my PCP can swing those labs under insurance, but I will do a walk-in lab for at least the DHT, if he can't swing it for me.
I am a quality over quantity sort of guy. I also believe Adaptive Theory (as being advanced by people like Dr. Gatenby at Moffitt) is really on to something significant. Your light-touch treatment approach seems to have worked well for you, so you can see my interest in your story. Anyone who departs from SOC is looking for "proof of concept" validation and it is only by sharing our successes and failures that we are able to do that. I firmly believe that not so many years in the future, people will look back at the way PCa and many other cancers are being treated today and will say loudly, "What the Hell were they thinking?"
In the meantime we all carry on and work to get the best QOL possible while still keeping the cancer sleeping in the closet. I've actually come to think of it not as a war or battle, but more as a dance I do with my own body and its metabolism. I'm looking for a two step forward with no more than one backward treatment partner from here on out.
How's that for an "abbreviated" version? Comments are welcomed. Thanks for you interest. Outliers are truly out there. Be Safe / Stay Well K9
I would wait to see the repeat PSA... there is the potential for lab error... The DHT and E2 levels also to see the lay of the hormonal landscape is a good idea. Best of luck K9 Caped Crusader... testing next week... got rescheduled at Cleveland for this month due to MO change in availability... Prayers for us both..
Try not stress on those labs, Fish. After almost 14 years of labs, scans, pokes and prods, I no longer suffer from PPLSSD ( Pre/Post Lab/Scan Stress Disorder). Helps to be an oldtimer like me - who feels that every day out walking around is one more gift from the Gods.
After 3 years of testing, I have stopped stressing so much... You do what you can and that's all you can do... I feel good... and the ADT vacation has done wonders for my physical and mental well being... Sometimes the treatment is as bad or worse than the disease... This is why we need vaccines, new treatment protocols, ways to delay ADT and castrate resistance... the Science is Coming !!! I am preparing a 2 or 3 part series of posts that some may find interesting...
Yes, those treatment vacations are pretty special. When we get the T back, it make you realize how important it is for real QOL. The longer you live and the more you experience the physical and emotional extremes that life throws at you, the more you come to appreciate the times when QOL is good.
We all look forward to you next Mr. Fish science report. Be Safe & Well in the interim.
FYI: Dutasteride has a long half life as stated. Effect can be seen as long as 4-6 months after stopping. One cannot donate blood if they not been off dutateride for 6 months.
Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.
Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.
Fish consumption and PCa Mortality. A meta-analysis.